Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder.
about
Medical costs and hospitalizations among patients with depression treated with adjunctive atypical antipsychotic therapy: an analysis of health insurance claims data.A review of current evidence for vilazodone in major depressive disorder.Vilazodone for the treatment of major depressive disorder: focusing on its clinical studies and mechanism of action.Real-world determinants of adjunctive antipsychotic prescribing for patients with major depressive disorder and inadequate response to antidepressants: a case review studyAdjunctive aripiprazole therapy with escitalopram in patients with co-morbid major depressive disorder and alcohol dependence: clinical and neuroimaging evidence.Medical costs and utilization in patients with depression treated with adjunctive atypical antipsychotic therapy.
P2860
Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Cost-effectiveness of adjuncti ...... of major depressive disorder.
@en
Cost-effectiveness of adjuncti ...... of major depressive disorder.
@nl
type
label
Cost-effectiveness of adjuncti ...... of major depressive disorder.
@en
Cost-effectiveness of adjuncti ...... of major depressive disorder.
@nl
prefLabel
Cost-effectiveness of adjuncti ...... of major depressive disorder.
@en
Cost-effectiveness of adjuncti ...... of major depressive disorder.
@nl
P2093
P2860
P356
P1476
Cost-effectiveness of adjuncti ...... of major depressive disorder.
@en
P2093
Charu Taneja
George I Papakostas
Gerry Oster
Robert A Forbes
Ross A Baker
Yonghua Jing
P2860
P304
P356
10.1345/APH.1Q326
P407
P577
2012-05-01T00:00:00Z